ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation - report from ESC2021 episode artwork

EPISODE · Sep 7, 2021 · 14 MIN

ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation - report from ESC2021

from Medical Digest & Congress Report · host Medical Congress News

Prof. George Dangas speaks about the outcomes of the ENVISAGE-TAVI AF trial. Video: https://congressreport.eu/scientific-contents/interview:envisage-tavi-af-edoxaban-vs-vitamin-k-antagonists-after-tavi-patients-atrial-fibrillation

Episode metadata supplied by the publisher feed · Published Sep 7, 2021

Embed this episode

Ready to play

ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation - report from ESC2021

0:00 14:50

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 14 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on September 7, 2021.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!